Simon MooijaartJan 15, 2023
Great work by the talented Joosje Baltussen! Intriguing findings:
🇳🇱 Treatment/survival of Dutch older patients with metastatic colorectal cancer rapidly changed from 2005 to 2020:
📈 more best supportive care
📉 less chemotherapy
🔴 decreased survival since '14
🔗 https://onlinelibrary.wiley.com/doi/10.1002/ijc.34422
#geriatrics #geriONC #medMastodon
Show threadDr Margaret Gatti-MaysJan 3, 2023
Dr Nicole Williams, Associate Professor, is the OSU #ISPY2 site-PI, is the director of the OSU #BreastCancer CARE clinic (#geriOnc) and was recently named Fellowship Director for the OSU #BreastCancer #MedOncFellowship Accepting applicants now 🙂 @OSUCCC_James @OSUWexMed
Simon MooijaartDec 31, 2022

High 1-year #mortality in older patients with #esophageal #cancer: 36% in our study. 23% discontinued #treatment. #Comorbidity and dependency predicted discontinuation.

❗️ #Geriatric assessment helps decision making

🌐 https://t.co/6Glg4uWmSb
#geriatrics #oncology #geriONC #medmastodon

Geriatric assessment and treatment outcomes in a Dutch cohort of older patients with potentially curable esophageal cancer

Patients with potentially curable esophageal cancer can be treated with neo-adjuvant chemoradiotherapy followed by surgery or definitive chemoradiotherapy with curative intent. For frail older pati...

Taylor & Francis
Dr Sophie PILLERONDec 12, 2022

#Epiverse

It's #DAG time

Any thoughts on the DAG below representing the relationship between receipt of #surgery and #death within 1 year of diagnosis in patients with #ColonCancer?

Clear enough? Did I forget something?

#GeriOnc

Dr Sophie PILLERONDec 4, 2022

Hello #GeriOnc community & others, with colleagues we described age-related diff in #coloncancer and #rectalcancer #survival using #SEER data in the #US.
Our work is available on medrxiv server and ready for your comments:
https://medrxiv.org/cgi/content/short/2022.11.29.22282871v1

#cancer #epiverse #epidemiology #description #AgeDisparities #GeriatricOncology